Reckitt Benckiser Group appoints Olivier Bohuon to its Board as Non-Executive Director

– UK, Slough –  Reckitt Benckiser Group plc (LON: RB), today announced the appointment of Olivier Bohuon to its Board as a non-executive director, effective January 1st, 2021.

“I am delighted that Olivier has agreed to join the Board. He is a successful leader, with many years of experience as CEO of a large global company. Olivier has deep experience in healthcare products and markets and will bring great insight to the Board and we welcome his appointment.” said Board Chairman, Chris Sinclair.

He will also join the Remuneration Committee.

About

Mr Bohuon was CEO of FTSE 100 medical devices company Smith & Nephew from 2011 to 2018. Before that role, he served as CEO of healthcare, cosmetology and pharmaceutical company Laboratoires Pierre Fabre from 2010-2011. Before that he worked for Abbott Laboratories from 2003 to 2010, rising to corporate executive vice president and president of the pharmaceutical products division. Mr Bohuon previously worked at GlaxoSmithKline plc for a number of years in positions of increasing seniority.

Mr Bohuon is a member of the supervisory board of Virbac SA, is Chairman of the Board of Directors of Leo Pharma in Denmark and serves on the Board of Takeda Pharmaceuticals in Japan. He also served on the Board of Smiths Industries from July 2018 to November 2020.

Mr Bohuon is a member of the National Pharmacy Academy and the Academy of Technologies. He became a Knight of the Legion of Honour in 2007. He has a doctorate in pharmacy from the University of Paris-Sud and MBA from HEC Paris.

About Reckitt Benckiser Group plc

Reckitt Benckiser Group plc is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.

RB is proud to have a stable of trusted household brands found in households in more than 190 countries. These include Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite, Air Wick and more. 20 million RB products a day are bought by consumers globally.

RB’s passion to put consumers and people first, to seek out new opportunities, to strive for excellence in all that we do, and to build shared success with all our partners, while doing the right thing, always is what guides the work of our 40,000+ diverse and talented colleagues worldwide.

For more information : http://www.rb.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.